CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands		Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Beginning balance (in shares) at Jan. 30, 2022			71,982,000
Beginning balance at Jan. 30, 2022		$ 1,664,207	$ 720	$ 600,942	$ 1,074,084	$ (10,828)	$ (711)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		254,113			254,113
Foreign currency translation adjustments		(1,514)				(1,514)
Change in fair value of derivative financial instruments, net of tax		93				93
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(18)				(18)
Conversion/release of stock-based awards (in shares)	[1]		617,000
Conversion/release of stock-based awards	[1]	(78,508)	$ 6	(78,142)			(372)
Repurchase of common stock (in shares)			(3,380,000)
Repurchases of common stock		(501,075)	$ (33)	(18,590)	(482,452)
Reissuance of treasury stock under stock-based compensation plans	[1]	0		(344)	0		344
Stock-based compensation expense		28,339		28,339
Dividends declared		(55,893)			(55,893)
Ending balance (in shares) at May. 01, 2022			69,219,000
Ending balance at May. 01, 2022		1,309,744	$ 693	532,205	789,852	(12,267)	(739)
Beginning balance (in shares) at Jan. 30, 2022			71,982,000
Beginning balance at Jan. 30, 2022		1,664,207	$ 720	600,942	1,074,084	(10,828)	(711)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		772,911
Foreign currency translation adjustments		(8,057)
Change in fair value of derivative financial instruments, net of tax		1,188
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(151)
Ending balance (in shares) at Oct. 30, 2022			66,556,000
Ending balance at Oct. 30, 2022		1,412,934	$ 666	553,698	877,157	(17,848)	(739)
Beginning balance (in shares) at May. 01, 2022			69,219,000
Beginning balance at May. 01, 2022		1,309,744	$ 693	532,205	789,852	(12,267)	(739)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		267,075			267,075
Foreign currency translation adjustments		(1,385)				(1,385)
Change in fair value of derivative financial instruments, net of tax		26				26
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(5)				(5)
Conversion/release of stock-based awards (in shares)	[1]		26,000
Conversion/release of stock-based awards	[1]	(767)		(767)
Repurchase of common stock (in shares)			(2,188,000)
Repurchases of common stock		(265,349)	$ (22)	(12,519)	(252,808)
Stock-based compensation expense		22,976		22,976
Dividends declared		(54,036)			(54,036)
Ending balance (in shares) at Jul. 31, 2022			67,057,000
Ending balance at Jul. 31, 2022		1,278,279	$ 671	541,895	750,083	(13,631)	(739)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		251,723			251,723
Foreign currency translation adjustments		(5,158)				(5,158)
Change in fair value of derivative financial instruments, net of tax		1,069				1,069
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(128)				(128)
Conversion/release of stock-based awards (in shares)	[2]		13,000
Conversion/release of stock-based awards	[2]	(1,156)		(1,156)
Repurchase of common stock (in shares)			(514,000)
Repurchases of common stock		(74,531)	$ (5)	(3,010)	(71,516)
Stock-based compensation expense		15,969		15,969
Dividends declared		(53,133)			(53,133)
Ending balance (in shares) at Oct. 30, 2022			66,556,000
Ending balance at Oct. 30, 2022		1,412,934	$ 666	553,698	877,157	(17,848)	(739)
Beginning balance (in shares) at Jan. 29, 2023			66,226,000
Beginning balance at Jan. 29, 2023		1,701,051	$ 663	573,117	1,141,819	(13,809)	(739)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		156,531			156,531
Foreign currency translation adjustments		(2,205)				(2,205)
Change in fair value of derivative financial instruments, net of tax		242				242
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(486)				(486)
Conversion/release of stock-based awards (in shares)	[2]		498,000
Conversion/release of stock-based awards	[2]	(49,518)	$ 5	(49,322)			(201)
Repurchase of common stock (in shares)	[3]		(2,502,000)
Repurchases of common stock	[3]	(302,401)	$ (25)	(14,803)	(286,573)		(1,000)
Reissuance of treasury stock under stock-based compensation plans	[2]	0		(334)	(180)		514
Stock-based compensation expense		23,282		23,282
Dividends declared		(59,671)			(59,671)
Ending balance (in shares) at Apr. 30, 2023			64,222,000
Ending balance at Apr. 30, 2023		1,466,825	$ 643	531,940	951,926	(16,258)	(1,426)
Beginning balance (in shares) at Jan. 29, 2023			66,226,000
Beginning balance at Jan. 29, 2023		1,701,051	$ 663	573,117	1,141,819	(13,809)	(739)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		595,323
Foreign currency translation adjustments		(4,062)
Change in fair value of derivative financial instruments, net of tax		163
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(896)
Ending balance (in shares) at Oct. 29, 2023			64,135,000
Ending balance at Oct. 29, 2023		1,813,234	$ 642	572,406	1,260,216	(18,604)	(1,426)
Beginning balance (in shares) at Apr. 30, 2023			64,222,000
Beginning balance at Apr. 30, 2023		1,466,825	$ 643	531,940	951,926	(16,258)	(1,426)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		201,507			201,507
Foreign currency translation adjustments		2,171				2,171
Change in fair value of derivative financial instruments, net of tax		(157)				(157)
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(296)				(296)
Conversion/release of stock-based awards (in shares)	[2]		13,000
Conversion/release of stock-based awards	[2]	(432)		(432)
Repurchase of common stock (in shares)	[3]		(90,000)
Repurchases of common stock	[3]	(10,096)	$ (1)	(548)	(9,547)
Stock-based compensation expense		20,547		20,547
Dividends declared		(59,114)			(59,114)
Ending balance (in shares) at Jul. 30, 2023			64,145,000
Ending balance at Jul. 30, 2023		1,620,955	$ 642	551,507	1,084,772	(14,540)	(1,426)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		237,285			237,285
Foreign currency translation adjustments		(4,028)				(4,028)
Change in fair value of derivative financial instruments, net of tax		78				78
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(114)				(114)
Conversion/release of stock-based awards (in shares)	[2]		11,000
Conversion/release of stock-based awards	[2]	(1,159)		(1,159)
Repurchase of common stock (in shares)			(21,000)
Repurchases of common stock		(3,014)	$ 0	(131)	(2,883)
Stock-based compensation expense		22,189		22,189
Dividends declared		(58,958)			(58,958)
Ending balance (in shares) at Oct. 29, 2023			64,135,000
Ending balance at Oct. 29, 2023		$ 1,813,234	$ 642	$ 572,406	$ 1,260,216	$ (18,604)	$ (1,426)

[1] Amounts are shown net of shares withheld for employee taxes

[2] Amounts are shown net of shares withheld for employee taxes.

[3] Repurchases of common stock include accrued excise taxes of $2.5 million as of October 29, 2023, which is recorded in retained earnings.